Topic: Neuroscience
Researchers found that boosting tiny structures called mitochondria in the brain can reverse memory loss. This could lead to new treatments for dementia.
Mitochondria are often referred to as the power plants of cells, but they play an even more crucial role in the brain. These tiny structures provide energy to neurons, allowing them to communicate and form memories.
A team of scientists from Inserm and the University of Bordeaux at the NeuroCentre Magendie, along with researchers from the Université de Moncton in Canada, made a groundbreaking discovery. They found that faulty mitochondrial activity is directly linked to cognitive symptoms associated with neurodegenerative diseases like dementia.
To understand this link better, the team created a tool that allowed them to temporarily increase mitochondrial activity in animal models of neurodegenerative disease. When they boosted the brain's energy machinery, memory problems improved. This suggests that mitochondria may not simply break down after brain disease begins, but their failure could contribute to symptoms like dementia.
The findings are still early and were observed in animal models, but they point to a promising possibility: restoring mitochondrial function could become a strategy for slowing or reducing dementia symptoms.
Mitochondria matter especially in the brain, which consumes a large amount of energy. Neurons depend on this energy to send signals to one another. When mitochondrial activity drops, neurons may no longer have enough power to work properly, leading to memory and thinking problems.
Neurodegenerative diseases involve the gradual decline of neuronal function, followed by the death of brain cells. In Alzheimer's disease, researchers have long observed that mitochondrial problems appear alongside neuronal degeneration, often before cells die.
A Tool Designed to Recharge Mitochondria
To explore this question, the researchers developed a tool called mitoDreadd-Gs. This receptor was designed to activate G proteins directly inside mitochondria, which stimulated mitochondrial activity. When activated in the brain, mitochondrial activity returned to normal levels, and memory performance improved in mouse models of dementia.
A Possible New Target for Dementia Research
Giovanni Marsicano, Inserm research director and co-senior author of the study, explains that this work establishes a cause-and-effect link between mitochondrial dysfunction and symptoms related to neurodegenerative diseases. This suggests that impaired mitochondrial activity could be at the origin of the onset of neuronal degeneration.
The results do not mean that a treatment is ready for patients. The work was performed in animal models, and much more research is needed to determine whether similar approaches could be safe, durable, and effective in humans. Still, the findings add momentum to a growing understanding of the role mitochondria play in brain function.
Why It Matters
This breakthrough could lead to new treatments for dementia, which affects millions of people worldwide. Understanding how mitochondrial activity contributes to memory loss can help scientists develop more effective strategies to combat this devastating disease.
Key Facts
- Scientists found that boosting mitochondria in the brain can reverse memory loss.
- Faulty mitochondrial activity is directly linked to cognitive symptoms associated with neurodegenerative diseases like dementia.
- The researchers developed a tool called mitoDreadd-Gs to temporarily increase mitochondrial activity in animal models of neurodegenerative disease.
- Boosting mitochondrial activity improved memory performance in mouse models of dementia.
- This breakthrough could lead to new treatments for dementia, which affects millions of people worldwide.
Key Terms
- Mitochondria
- Tiny structures inside cells that provide energy
Implications
This breakthrough could lead to new treatments for dementia, which affects millions of people worldwide. Understanding how mitochondrial activity contributes to memory loss can help scientists develop more effective strategies to combat this devastating disease.
Source: https://www.sciencedaily.com/releases/2026/05/260515234803.htm
Journal Reference:
- Antonio C. Pagano Zottola, Rebeca Martín-Jiménez, Gianluca Lavanco, Geneviève Hamel-Côté, Carla Ramon-Duaso, Rui S. Rodrigues, Yamuna Mariani, Mehtab Khan, Filippo Drago, Stephanie Jean, Itziar Bonilla-Del Río, Daniel Jimenez-Blasco, Jon Egaña-Huguet, Abel Eraso-Pichot, Sandra Beriain, Astrid Cannich, Laura Vidal-Palencia, Rosmara Infantino, Francisca Julio-Kalajzić, Doriane Gisquet, Ania Goncalves, Inas Al-Younis, Yann Baussan, Stephane Duvezin-Caubet, Anne Devin, Edgar Soria-Gomez, Nagore Puente, Juan P. Bolaños, Pedro Grandes, Sandrine Pouvreau, Arnau Busquets-Garcia, Giovanni Marsicano, Luigi Bellocchio, Etienne Hebert-Chatelain. Potentiation of mitochondrial function by mitoDREADD-Gs reverses pharmacological and neurodegenerative cognitive impairment in mice. Nature Neuroscience, 2025; 28 (9): 1844 DOI: 10.1038/s41593-025-02032-y
Leave a Comment